A Mitochondrial Origin for Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Through CHCHD10 Involvement
Overview
Authors
Affiliations
Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy. In all patients, muscle biopsy showed ragged-red and cytochrome c oxidase-negative fibres with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Patient fibroblasts present with respiratory chain deficiency, mitochondrial ultrastructural alterations and fragmentation of the mitochondrial network. Interestingly, expression of matrix-targeted photoactivatable GFP showed that mitochondrial fusion was not inhibited in patient fibroblasts. Using whole-exome sequencing we identified a missense mutation (c.176C>T; p.Ser59Leu) in the CHCHD10 gene that encodes a coiled-coil helix coiled-coil helix protein, whose function is unknown. We show that CHCHD10 is a mitochondrial protein located in the intermembrane space and enriched at cristae junctions. Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and ultrastructural major abnormalities including loss, disorganization and dilatation of cristae. The observation of a frontotemporal dementia-amyotrophic lateral sclerosis phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families with pathologically proven frontotemporal dementia-amyotrophic lateral sclerosis. We identified the same missense p.Ser59Leu mutation in one of these families. This work opens a novel field to explore the pathogenesis of the frontotemporal dementia-amyotrophic lateral sclerosis clinical spectrum by showing that mitochondrial disease may be at the origin of some of these phenotypes.
Gao G, Shi Y, Deng H, Krainc D Nat Commun. 2025; 16(1):1982.
PMID: 40011434 PMC: 11865444. DOI: 10.1038/s41467-025-57142-9.
Parkinson's disease and glucose metabolism impairment.
Chen L, Wang C, Qin L, Zhang H Transl Neurodegener. 2025; 14(1):10.
PMID: 39962629 PMC: 11831814. DOI: 10.1186/s40035-025-00467-8.
The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review.
Ferretti S, Zanella I Int J Mol Sci. 2024; 25(23).
PMID: 39684697 PMC: 11640923. DOI: 10.3390/ijms252312987.
OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution.
Macuada J, Molina-Riquelme I, Vidal G, Perez-Bravo N, Vasquez-Trincado C, Aedo G Cell Death Dis. 2024; 15(11):870.
PMID: 39616197 PMC: 11608329. DOI: 10.1038/s41419-024-07165-9.
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis.
Ito D, Okada K Ann Clin Transl Neurol. 2024; 11(12):3054-3063.
PMID: 39473221 PMC: 11651183. DOI: 10.1002/acn3.52234.